Nektar Therapeutics
NKTR
#5687
Rank
โ‚ฌ0.99 B
Marketcap
48,87ย โ‚ฌ
Share price
-1.37%
Change (1 day)
238.13%
Change (1 year)

Nektar Therapeutics (NKTR) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚ฌ0.18 Billion

According to Nektar Therapeutics 's latest financial reports the company's total liabilities are โ‚ฌ0.18 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Nektar Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ0.23 B-3.29%
2023-12-31โ‚ฌ0.24 B-24.66%
2022-12-31โ‚ฌ0.32 B-17.03%
2021-12-31โ‚ฌ0.38 B3.01%
2020-12-31โ‚ฌ0.37 B-26.52%
2019-12-31โ‚ฌ0.51 B35.02%
2018-12-31โ‚ฌ0.37 B7.76%
2017-12-31โ‚ฌ0.35 B-23.22%
2016-12-31โ‚ฌ0.45 B1.53%
2015-12-31โ‚ฌ0.45 B35.09%
2014-12-31โ‚ฌ0.33 B-12.25%
2013-12-31โ‚ฌ0.37 B11.43%
2012-12-31โ‚ฌ0.34 B8.27%
2011-12-31โ‚ฌ0.31 B-2.77%
2010-12-31โ‚ฌ0.32 B-1.98%
2009-12-31โ‚ฌ0.33 B24.65%
2008-12-31โ‚ฌ0.26 B-24.25%
2007-12-31โ‚ฌ0.34 B-14.72%
2006-12-31โ‚ฌ0.41 B-8.64%
2005-12-31โ‚ฌ0.44 B119.36%
2004-12-31โ‚ฌ0.20 B-43.08%
2003-12-31โ‚ฌ0.35 B-6.02%
2002-12-31โ‚ฌ0.38 B-14.89%
2001-12-31โ‚ฌ0.44 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
โ‚ฌ69.16 B 37,133.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ99.31 B 53,370.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ66.68 B 35,800.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
โ‚ฌ34.95 M-81.18%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ58.82 B 31,567.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
โ‚ฌ11.89 B 6,305.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
โ‚ฌ0.51 B 175.63%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
โ‚ฌ97.51 B 52,400.91%๐Ÿ‡บ๐Ÿ‡ธ USA